ArticleJournal of advanced pharmaceutical technology & research
Low-molecular-weight peptides from deer antler velvet: Antioxidant potential, biosafety, and synergistic interaction with nanomelanin.
Article in Journal of advanced pharmaceutical technology & research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Deer antler velvet (DAV) is a precious pharmaceutical source. Low-molecular-weight peptides (LMWPs) extracted from DAV have been reported as promising pharmaceutical ingredients with various potential applications across different health care areas. Components, molecular weights, and bioactivities of DAV's peptides may vary depending on the production protocols. This study optimised an enzyme-based protocol for DAV protein digestion to obtain DAV peptides (as LMWPs form) and investigated bioactivities of the LMWPs. Different enzymes as single forms and/or combined forms were applied for digestion of DAV to create DAV peptides. Then, DAV peptides were mapped by proteomics analysis using LC/MS system. It indicated that sequential treatment with pepsin and trypsin yielded a distinct pool of LMWPs of below 10 kDa. Moreover, 8288 LMWPs from 1405 DAV's proteins digested by combined pepsin and trypsin were mapped. This LMWPs sample exhibited strong antioxidant activity in the ABTS assay, with an antioxidant potential of 1 mg/mL, corresponding to that of 1.7 mg/mL Ascorbic acid. Interestingly, the mixture of LMWPs and nano-melanin exhibited synergistic antioxidant effects, resulting in a ~2-fold increase in relative antioxidant potential. In addition, LMWPs at concentrations ranging from 5 to 1000 µg/mL exhibited very low toxicity toward STO cells, and toward zebrafish embryos, with NOEC and LOEC values estimated at 193 mg/L and 289 mg/L, respectively. This study suggests an enzymatic method to digest DAV's proteins to extract bioactive LMWPs, and implies possible combinations of the DAV's LMWPs and nano-melanin to develop nutritional foods and/or pharmaceutical preparations for antioxidant applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.